Pharmacy Benefit Manager Pricing and Spread Pricing for High-Utilization Generic Drugs

This cross-sectional study uses Medicare Part D claims for high-utilization generic drugs to analyze gross profits accumulated by pharmacy benefit managers, pharmacies, wholesalers, and manufacturers in the pharmaceutical supply chain.

Detalles Bibliográficos
Autores principales: Mattingly, T. Joseph, Ben-Umeh, Kenechukwu C., Bai, Ge, Anderson, Gerard F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589804/
https://www.ncbi.nlm.nih.gov/pubmed/37862035
http://dx.doi.org/10.1001/jamahealthforum.2023.3660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589804/
https://www.ncbi.nlm.nih.gov/pubmed/37862035
http://dx.doi.org/10.1001/jamahealthforum.2023.3660

Ejemplares similares